These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27059202)

  • 1. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
    Oyer JL; Pandey V; Igarashi RY; Somanchi SS; Zakari A; Solh M; Lee DA; Altomare DA; Copik AJ
    Cytotherapy; 2016 May; 18(5):653-63. PubMed ID: 27059202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of highly cytotoxic natural killer cells for treatment of acute myelogenous leukemia using a feeder-free, particle-based approach.
    Oyer JL; Igarashi RY; Kulikowski AR; Colosimo DA; Solh MM; Zakari A; Khaled YA; Altomare DA; Copik AJ
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):632-9. PubMed ID: 25576425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.
    Fujisaki H; Kakuda H; Shimasaki N; Imai C; Ma J; Lockey T; Eldridge P; Leung WH; Campana D
    Cancer Res; 2009 May; 69(9):4010-7. PubMed ID: 19383914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival.
    Oyer JL; Croom-Perez TJ; Hasan MF; Rivera-Huertas JA; Gitto SB; Mucha JM; Zhu X; Altomare DA; Igarashi RY; Copik AJ
    Front Immunol; 2024; 15():1383281. PubMed ID: 38711506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
    Masuyama J; Murakami T; Iwamoto S; Fujita S
    Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.
    Seay K; Church C; Zheng JH; Deneroff K; Ochsenbauer C; Kappes JC; Liu B; Jeng EK; Wong HC; Goldstein H
    J Virol; 2015 Jun; 89(12):6264-74. PubMed ID: 25833053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells differentiated in vitro from cord blood CD34
    Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
    Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients.
    Siegler U; Meyer-Monard S; Jörger S; Stern M; Tichelli A; Gratwohl A; Wodnar-Filipowicz A; Kalberer CP
    Cytotherapy; 2010 Oct; 12(6):750-63. PubMed ID: 20491532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells.
    Baek HJ; Kim JS; Yoon M; Lee JJ; Shin MG; Ryang DW; Kook H; Kim SK; Cho D
    Anticancer Res; 2013 May; 33(5):2011-9. PubMed ID: 23645750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expansion of human natural killer cells ex vivo].
    Huang QS; Li Q; Huang Y; Shang P; Zhang MJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1167-9. PubMed ID: 19068202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
    Thangaraj JL; Phan MT; Kweon S; Kim J; Lee JM; Hwang I; Park J; Doh J; Lee SH; Vo MC; Chu TH; Song GY; Ahn SY; Jung SH; Kim HJ; Cho D; Lee JJ
    Cancer Immunol Immunother; 2022 Mar; 71(3):613-625. PubMed ID: 34282497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia.
    Mani R; Rajgolikar G; Nunes J; Zapolnik K; Wasmuth R; Mo X; Byrd JC; Lee DA; Muthusamy N; Vasu S
    Cytotherapy; 2020 Jul; 22(7):369-376. PubMed ID: 32303428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple effects of IL-21 on human NK cells in ex vivo expansion.
    Li Q; Ye LJ; Ren HL; Huyan T; Li J; Shi JL; Huang QS
    Immunobiology; 2015 Jul; 220(7):876-88. PubMed ID: 25758713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.
    Harada H; Suzu S; Ito T; Okada S
    Eur J Immunol; 2005 Dec; 35(12):3599-609. PubMed ID: 16304638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreserved PM21-Particle-Expanded Natural Killer Cells Maintain Cytotoxicity and Effector Functions
    Oyer JL; Croom-Perez TJ; Dieffenthaller TA; Robles-Carillo LD; Gitto SB; Altomare DA; Copik AJ
    Front Immunol; 2022; 13():861681. PubMed ID: 35464440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded clinical-grade membrane-bound IL-21/4-1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo.
    Zhao XY; Jiang Q; Jiang H; Hu LJ; Zhao T; Yu XX; Huang XJ
    Eur J Immunol; 2020 Sep; 50(9):1374-1385. PubMed ID: 32357256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exposure to interleukin-21 at various time points on human natural killer cell culture.
    Lim DP; Jang YY; Kim S; Koh SS; Lee JJ; Kim JS; Thi Phan MT; Shin DJ; Shin MG; Lee SH; Yoon M; Kim SK; Yoon JH; Park MH; Cho D
    Cytotherapy; 2014 Oct; 16(10):1419-30. PubMed ID: 24950680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21.
    Kweon S; Phan MT; Chun S; Yu H; Kim J; Kim S; Lee J; Ali AK; Lee SH; Kim SK; Doh J; Cho D
    Front Immunol; 2019; 10():879. PubMed ID: 31105701
    [No Abstract]   [Full Text] [Related]  

  • 20. Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody.
    Lee HR; Son CH; Koh EK; Bae JH; Kang CD; Yang K; Park YS
    Sci Rep; 2017 Sep; 7(1):11075. PubMed ID: 28894091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.